You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 7, February 17, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Transdermal Fentanyl for Postoperative Pain Management

A Double-blind Placebo Study

Robert A. Caplan, MD; L. Brian Ready, MD; Rollin V. Oden, MD; Frederick A. Matsen III, MD; Michael L. Nessly; Gayle L. Olsson, RN, MN

JAMA. 1989;261(7):1036-1039.


Abstract

A double-blind, placebo-controlled, randomized design was used to evaluate the safety and efficacy of transdermal fentanyl citrate for postoperative pain management in 42 healthy adult patients undergoing major shoulder surgery. Transdermal systems rated to deliver fentanyl citrate at a rate of 75 µg/h were applied to the skin immediately prior to surgery and worn for 24 hours. Patients in the active group required significantly less morphine than the placebo group during the 24-hour period that systems were in place (0.8 ±0.61 vs 1.3 ±0.64 mg/h) and for the first 12 hours after removal (0.3 ± 0.36 vs 0.5 ± 0.32 mg/h). The incidence of vomiting was more frequent in the active group than in the placebo group (73% vs 30%), and respiratory rate in the active group was lower than in the placebo group during the 13- to 24-hour interval of system application (14±3 vs 16±2 breaths per minute). Nevertheless, transdermal fentanyl appears to be safe and effective after orthopedic surgery in healthy adult patients.

(JAMA 1989;260:1036-1039)



Author Affiliations

From the Department of Anesthesiology, RN-10, University of Washington School of Medicine, Seattle.


Footnotes

Reprint requests to Virginia Mason Medical Center, Anesthesiology Department, (B2-AN), PO Box 900, Seattle, WA 98111 (Dr Caplan).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The management of pain in terminally ill cancer patients with difficulty swallowing
Coluzzi and Fairbairn
AM J HOSP PALLIAT CARE 1999;16:731-737.
 

Review: Medication Delivery in the Short-Bowel Syndrome
McFadden et al.
JPEN J Parenter Enteral Nutr 1993;17:180-186.
ABSTRACT  

Review articles : Transdermal and inhalatory routes of opioid administration: the potential application in cancer pain
Ripamonti and Bruera
Palliat Med 1992;6:98-104.
ABSTRACT  

Management of Pain in the Critically Ill
Stevens and Edwards
J Intensive Care Med 1990;5:258-291.
ABSTRACT  

TRANSDERMAL ANALGESIA
JWatch General 1989;1989:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.